Oracle Corporation is downgraded to Hold due to ongoing market concerns about its high capital expenditures and negative free cash flow, despite strong revenue growth driven by cloud infrastructure. The company reported a record $23 billion in operating cash flow but spent $28 billion on capital expenditures, pressuring credit ratings and investor confidence. Shares are trading below historical averages as skepticism grows over long-term backlog conversion and slowing AI development. The stock is expected to consolidate in the near term amid these challenges.
Oracle's stock fell 5% after the company revealed that layoff costs increased by $700 million due to severance and AI-related workforce reductions, overshadowing Executive Chair Larry Ellison's canceled plan to sell $7.5 billion in shares. The negati...
Larry Ellison, Oracle's founder, canceled a plan to sell up to $7.5 billion in Oracle shares just one day after it was publicly disclosed. This move follows a dramatic $200 billion decline in his net worth over the past year, largely due to Oracle's ...
Oracle Health has introduced the Clinical AI Agent for nurses in the U.S., integrating AI-powered voice navigation, acute nursing summaries, and voice-enabled charting into its EHR system. This tool helps nurses quickly access patient information, do...
Oracle co-founder Larry Ellison has canceled his plan to sell up to 50 million Oracle shares, worth about $7.5 billion, which was set to expire in October. No shares were sold under this plan, and Ellison has no other plans to sell his stock. Oracle'...
Larry Ellison, Oracle's controlling shareholder, canceled a planned $7.5 billion stock sale, signaling his confidence in the company's future amid strong AI cloud growth. The cancellation removes selling pressure as Oracle's stock had fallen about 16...
